Description
Innovations - Découvertes
Mais aussi des synthèses, des études et des recherches.
- Process evaluation of the implementation of a personalized digital care pathway tool using the RE-AIM framework
Author Names: Heijsters F.A.C.J.,Cornelissen E.C.,de Bruijne M.C.,Bouman M.,Mullender M.G.,van Nassau F. Database Source: Embase Daily Updates […]
- A comprehensive benchmark of tools for efficient genomic interval querying
Brief Bioinform. 2025 Jul 2;26(4):bbaf379. doi: 10.1093/bib/bbaf379.ABSTRACTEfficiently querying genomic intervals is fundamental to modern bioinformatics, enabling researchers to extract and analyze […]
- Synergistic innovation in organ-on-a-chip and organoid technologies: Reshaping the future of disease modeling, drug development and precision medicine
Author Names: Li B.,Tang Y.,Huang Z.,Ma L.,Song J.,Xue L. Database Source: Embase Daily Updates Journal Title: Protein & cell […]
- Proactive process evaluation of precision medicine platforms: A roadmap
Author Names: Cresswell K. Database Source: Embase Daily Updates Journal Title: BMJ Health and Care Informatics Article […]
- Multifunctional gold nanoclusters as next-generation theranostic platforms for disease management
Author Names: Sun Y.,Chen Y.,Hu X.,Liu A.,He L.,Dai A.,Wei T.,Wang S.,Gan Z. Database Source: Embase Daily Updates Journal Title: […]
- Operational and path dependencies impede the feasibility of hospital-based production of individually engineered drugs
Author Names: Zwart B.,Sulz S.,Dekker J.,Ijzerman M. Database Source: Embase Daily Updates Journal Title: Drug Discovery Today […]
- A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches
Brief Bioinform. 2025 Jul 2;26(4):bbaf355. doi: 10.1093/bib/bbaf355.ABSTRACTThe rapid advancement of high-throughput sequencing and other assay technologies has resulted in the generation of large […]
- Deep Genomics: Deep Learning-Based Analysis of Genome-Sequenced Data for Identification of Gene Alterations
Author Names: Kumar S.,Goel P. Database Source: Embase Daily Updates Journal Title: Article Title: Deep Genomics: […]
- Advances in nanorobotics for gastrointestinal surgery: a new frontier in precision medicine and minimally invasive therapeutics
Author Names: Rui Z.,Mehdizadeh S.,Abasi M.,Pilehvar Y. Database Source: Embase Daily Updates Journal Title: Journal of Robotic Surgery […]
- Revolutionizing personalized medicine using artificial intelligence: a meta-analysis of predictive diagnostics and their impacts on drug development
Author Names: Daemi A.,Kalami S.,Tahiraga R.G.,Ghanbarpour O.,Barghani M.R.R.,Hooshiar M.H.,Ozbolat G.,Yonden Z. Database Source: Embase Daily Updates […]
Axes CHUM
Cet onglet concerne exclusivement les quatre axes qui suivent : oncologie, neurosciences, cardiovasculaire et imagerie.
- TROP2-targeted molecular imaging: a promising tool for precision oncology
Author Names: Ye L.,Chen H.,Wu D. Database Source: Embase Daily Updates Journal Title: American Journal of Nuclear Medicine and Molecular […]
- Mapping the trajectory of psychotic symptoms and their interaction with antipsychotic treatment: a longitudinal network intervention study
Author Names: Sarti P.,Cecere G.,Edkins V.,Omlor W.,Blom J.M.C.,Homan P. Database Source: Embase Preprint Journal Title: medRxiv […]
- 3D Printing in Oral Drug Delivery: Technologies, Clinical Applications and Future Perspectives in Precision Medicine
Author Names: Saleh-Bey-Kinj Z.,Heller Y.,Socratous G.,Christodoulou P. Database Source: Embase Daily Updates Journal Title: Pharmaceuticals […]
- Tailoring antiseizure treatment with a wearable device: A proof-of-concept study in absence epilepsy
Author Names: Macea J.,Chatzichristos C.,Bhagubai M.,De Vos M.,Van Paesschen W. Database Source: Embase Weekly Updates Journal Title: […]
- Protective effect of CACNA1A deficiency in oligogenic refractory epilepsy with CACNA1A-CELSR2 digenic mutations
Author Names: Liu C.-Q.,Sun M.-Z.,Lin Y.-M.,Zhang X.-X.,Huang R.-N.,He M.-F.,Luo S.,Luo S.-Y.,Huang T.,Jiang N.,Luo J.,Zhang J.-X.,Chen P.-R.,Dai X.,Han T.-A.,Liao W.-P.,Peng R.-C.,Qiao J.-D. […]
- The evolution of health data ecosystems: An international survey
Author Names: Lerner-Ellis J.P.,Price E.M.,Subhani S.,Boughtwood T.,Brion M.-J.,Rendon A.,Cividanes L.,Gemmer J.,Ciofani D.,Bertin N.,Wee S.S.,Robertson S.,Baz B.,Crameri K.,Osterle S.,Wirta […]
- Supporting Participant Engagement in Cancer Genomics Research in Rare Cancers: A Qualitative Study of Patients, Caregivers, and Advocates
Cancer Control. 2025 Jan-Dec;32:10732748251364041. doi: 10.1177/10732748251364041. Epub 2025 Jul 28.ABSTRACTIntroductionThe purpose of this study was to identify patterns and themes that support […]
- Treating Cardiovascular Disorders with Personalized Medicine
Author Names: Garg I.,Kumar H.,Verma M.,Chauhan I.,Panwar V. Database Source: Embase Daily Updates Journal Title: Cardiovascular and […]
- MetaGeno: a chromosome-wise multi-task genomic framework for ischaemic stroke risk prediction
Brief Bioinform. 2025 Jul 2;26(4):bbaf348. doi: 10.1093/bib/bbaf348.ABSTRACTCurrent genome-wide association studies provide valuable insights into the genetic basis of ischaemic stroke (IS) risk. […]
- Precision Medicine and Cardiac Channelopathies: Human iPSCs Take the Lead
Author Names: Sebastian S.A.,Panthangi V.,Sethi Y.,Padda I.,Khan U.,Affas Z.R.,Mareddy C.,Dolack L.,Johal G. Database Source: Embase Weekly Updates […]
- Transforming clinical cardiology through neural networks and deep learning: A guide for clinicians
Author Names: Sutanto H. Database Source: Embase Weekly Updates Journal Title: Current Problems in Cardiology Article […]
- Exploring Cancer Patients' and Caregivers' Perspectives and Knowledge Regarding Biomarker Testing in Canada
Author Names: Mksyartinian P.,Xu S.,Barroma C.,Pelaez S.,Stein B.D. Database Source: Embase Daily Updates Journal Title: Current Oncology […]
Applications cliniques
- Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer
Researchers are leading the nation in using powerful and precise radioactive drugs to treat people with complex cancers. ROCHESTER, Minn. — Mayo Clinic has treated the first person in the […]
- Targeting the MAP Kinase Pathway in Colorectal Cancer: A Journey in Personalized Medicine
Author Names: Appleyard J.W.,Williams C.J.M.,Manca P.,Pietrantonio F.,Seligmann J.F. Database Source: Embase Weekly Updates Journal Title: […]
- Individualised Medicine: Application of a Personalised Approach in Clinical Practice
Author Names: Maltsev D.,Tyravska Y.,Shpryakha Y.,Kaminskyy V.,Merzliak S. Database Source: Embase Daily Updates Journal Title: Journal of […]
- CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential
Author Names: Far B.F.,Akbari M.,Habibi M.A.,Katavand M.,Nasseri S. Database Source: Embase Daily Updates Journal Title: Cell Proliferation […]
- A clinical road map for single-cell omics
Author Names: Skinnider M.A.,Courtine G.,Bloch J.,Squair J.W. Database Source: Embase Daily Updates Journal Title: Cell […]
- Exploring Clinicians' and Patients' Acceptance and Utilization of a Digital Solution to Support Individualized Care in Diabetes Specialist Outpatient Care (DigiDiaS): Qualitative Study
JMIR Hum Factors. 2025 Jul 8;12:e70301. doi: 10.2196/70301.ABSTRACTBACKGROUND: With the increasing prevalence of type 1 diabetes alongside limited health care resources, the need for more sustainable […]
- Are we properly evaluating genetic and genomic testing? A systematic review of health technology assessment reports
J Transl Med. 2025 Jul 7;23(1):749. doi: 10.1186/s12967-025-06703-z.ABSTRACTBACKGROUND: Despite advances in precision medicine, the translation of genetic and genomic technologies into routine […]
Publications CRCHUM
- Exome Sequencing in Pacific Islanders With Nephropathies of Unknown Origin
Kidney Int Rep. 2025 Mar 10;10(6):2054-2057. doi: 10.1016/j.ekir.2025.03.005. eCollection 2025 Jun.NO ABSTRACTPMID:40630292 | PMC:PMC12230993 | DOI:10.1016/j.ekir.2025.03.005
- Moving Beyond Race, Geographical Origin, and Ethnicity: Genomic Insights as a Path Forward in Nephrology Care
Nephrol Dial Transplant. 2025 Jul 3:gfaf124. doi: 10.1093/ndt/gfaf124. Online ahead of print.NO ABSTRACTPMID:40608521 | DOI:10.1093/ndt/gfaf124
- The mutagenic forces shaping the genomes of lung cancer in never smokers
Nature. 2025 Jul 2. doi: 10.1038/s41586-025-09219-0. Online ahead of print.ABSTRACTLung cancer in never smokers (LCINS) accounts for around 25% of all lung cancers1,2 and has been associated with […]
Enseignement - Didactique
- Educating the Next-Generation Expert in Nephrology Genetics
Semin Nephrol. 2025 Jul 15:151648. doi: 10.1016/j.semnephrol.2025.151648. Online ahead of print.ABSTRACTThe importance of genetics and genomics in general nephrology has rapidly ascended within the […]
- Does Education Design Matter? Evaluating an Evidence-Based Continuing Education Intervention on Genomic Testing for Primary Care; a Pre-Test Post-Test Study
J CME. 2025 Jul 21;14(1):2526234. doi: 10.1080/28338073.2025.2526234. eCollection 2025.ABSTRACTBACKGROUND: : Quality continuing education (CE) interventions should be effective, fit-for-purpose, and […]
- BioSTEM: A modern educational tool for research and innovation in the field of molecular biology and personalized medicine
Hum Genomics. 2025 Jul 14;19(1):82. doi: 10.1186/s40246-025-00786-x.ABSTRACTPersonalized Medicine has the potential to transform modern healthcare by tailoring medical decisions to an individual's […]
- Genomic literacy in nursing: a systematic scoping review of the literature
BMJ Open. 2025 Jul 13;15(7):e100054. doi: 10.1136/bmjopen-2025-100054.ABSTRACTOBJECTIVE: To map the available evidence on genomic literacy among clinical nurses, nursing students and nursing […]
Actualité - Formation
- Mayo Clinic AI tool finds early signs of blood mutations linked to cancer and heart disease
(Video animation shows blood stem cells dividing and multiplying. Getty Images). Deep inside the body, a slow-growing cluster of mutated blood cells can form. This cluster, found in 1 […]
- Rapport annuel de Génome Canada 2024-2025
Au nom du conseil d’administration et du personnel, nous sommes heureux de vous communiquer le Rapport annuel 2024-2025 de Génome Canada, Exploiter la génomique pour un meilleur impact.Depuis 25 […]
- Many All of Us participants give us samples of blood, urine, or saliva for research. These samples provide a lot of information about health and DNA. Researchers can study data from these samples to make discoveries. The samples are stored and protected in a lab called a biobank.
All of Us processes your samples and stores information about them on our secure computer systems. We lock samples in secure freezers and they are marked by ID numbers, not names or any other information that could identify the participant. Only a few authorized people can access them, and we make sure they are only used for health research: https://allof-us.org/4f3tJTW
#DNA #privacy #HealthResearch #JoinAllofUs
Many All of Us participants give us samples of blood, urine, or saliva for research. These samples provide a lot of information about health and DNA. Researchers can study data from these samples to […]
- GA4GH 13th Plenary
- Using AI to interpret prostate cancer MRIs could reduce radiologist workload and give more patients access - Ontario Institute for Cancer Research
A machine learning tool was able to accurately triage prostate cancer in OICR-supported research. New research suggests that AI has the potential to improve the efficiency of prostate cancer […]
- Communicating clearly about data sharing in genomics
Amorim M, Silva S, Maia T, de Freitas C. Benefits and risks of sharing genetic data for research purposes: the views of patients and carers. Eur J Pub Health, 30, Issue Supplement_5, September […]
- The perceived risks of sharing genomic data with researchers
About us Learn how GA4GH helps expand responsible genomic data use to benefit human health.Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global […]
- Demande de propositions – Étude économique sur la génomique, la biotechnologie et la biorévolution
Génome Canada lance un appel d’offres et sollicite des propositions de la part d’entreprises ou de consortiums qualifiés afin de mener une étude de haute qualité sur l’impact économique de […]
- Mayo Clinic deploys NVIDIA Blackwell infrastructure to drive generative AI solutions in medicine
A group of consultants discuss and review a digital pathology image on a wall monitor. ROCHESTER, Minn. — Mayo Clinic took a pivotal step toward integrating AI solutions in the clinical […]
- Progress in gene therapy offers hope for long-term knee pain relief
Christopher Evans, Ph.D. For nearly three decades, Mayo Clinic researcher Christopher Evans, Ph.D., has pushed to expand gene therapy beyond its original scope of fixing rare, single-gene […]
- WHO establishes communities of practice for pathogen genomics surveillance
The International Pathogen Surveillance Network (IPSN), set up by the WHO Hub for Pandemic and Epidemic Intelligence, has set up three communities of practice (CoPs), each designed to drive […]
- Mayo Clinic researchers link CAR-T cell aging to cancer relapse
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, or CAR-T cell therapy. Over time, the […]
- Pharmacogenomics expert advances precision medicine for bipolar disorder - EurekAlert!
Pharmacogenomics expert advances precision medicine for bipolar disorder EurekAlert!
- Possible target identified for treatment for 50% of cancers
Image: High-resolution microscopy of a mesenchymal cancer cell that has been killed by inactivating the CDS2 gene. Prior to cell death, tiny lipid droplets accumulated, which are still visible as […]
- Le séquençage génomique désormais offert à tous les enfants atteints de cancer au Québec - Index Santé
Le séquençage génomique désormais offert à tous les enfants atteints de cancer au Québec Index Santé
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |